Advantage Silver Dental Arrest, LLC Report issue

For profit Phase 2
Founded: Redmond OR United States (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
2017
NCT03082196
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Advantage Silver Dental Arrest, LLC

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dental Caries (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3